Stock listing

T3X Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: T3X · GETTEX · EUR · DE

The selected listing for Telix Pharmaceuticals Limited is T3X:GETTEX. Telix Pharmaceuticals focuses on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer and other serious diseases. Recent news highlights their ongoing clinical trials and partnerships aimed at advancing their product pipeline. Investors can find relevant filings and upcoming events that may impact the company's market presence and strategic direction.

T3X:GETTEXEURDEUpdated July 21, 2026
Telix Pharmaceuticals Limited logo
Ticker
T3X:GETTEX
Asset type
Stock
Market cap
$3.71B
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Telix Pharmaceuticals Limited T3X:GETTEX stock context

The selected listing for Telix Pharmaceuticals Limited is T3X:GETTEX. Telix Pharmaceuticals focuses on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer and other serious diseases. Recent news highlights their ongoing clinical trials and partnerships aimed at advancing their product pipeline. Investors can find relevant filings and upcoming events that may impact the company's market presence and strategic direction.

Research Telix Pharmaceuticals Limited

Alternate listings